Your browser doesn't support javascript.
loading
Research progress of exogenous ketone body 3-hydroxybutyrate supplementation for human disease treat-ment / 实用医学杂志
The Journal of Practical Medicine ; (24): 3290-3296, 2023.
Article de Zh | WPRIM | ID: wpr-1020694
Bibliothèque responsable: WPRO
ABSTRACT
3-hydroxybutyrate(3HB),an anionic small molecule acid metabolite with a hydroxyl group,is a chiral molecule that exists in two enantiomeric forms.It is associated with cell growth,proliferation,and anti-oxida-tive stress,and demonstrates good biosafety when used within a specific range.In addition to epilepsy treatment,with the popularity of ketogenic diet in recent years,exogenous supplementation of 3HB for human has been gradu-ally found to be associated with a variety of metabolic diseases.This review describes the physiological function,physicochemical characteristics,toxicology and biological safety of 3HB,and its applications as potential drug mol-ecules in epilepsy,weight-loss(or weight control),systemic inflammation,hemorrhagic shock,cancer,inflammatory bowel disease,atherosclerosis,diabetes,osteoporosis,neurological diseases(e.g.,Parkinson's disease,Alzheimer's disease and Huntington's disease),muscular dystrophy,COVID-19,anti-aging and many other medical fields.This review also focuses on the discussion and prospect of the new methods and the potential limitations of exogenous 3HB supplementation for clinical transformation.
Mots clés
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: The Journal of Practical Medicine Année: 2023 Type: Article
Texte intégral: 1 Indice: WPRIM langue: Zh Texte intégral: The Journal of Practical Medicine Année: 2023 Type: Article